Updated:
INTEGRATED BIOPHARMA INC
Integrated BioPharma manufactures vitamins and nutritional supplements, with contract manufacturing, fulfillment and raw-material distribution.
Overview
Integrated BioPharma manufactures, markets and distributes vitamins, nutritional supplements and herbal products. Manhattan Drug Company operates its contract-manufacturing business, supplying distributors, multilevel marketers and specialized healthcare providers. Other operations include warehousing and fulfillment through MDC Warehousing and Distribution and raw-material distribution through Chem International. Its operating model centers on supplement production and related services. Its reported principal executive office is in Hillside, NJ (United States). For fiscal 2026, ended 2026-06-30, its originally reported results included revenue of USD 43,872,000; a net loss of USD 2,842,000; cash provided by operations of USD 1,241,000. At that year-end, it reported total assets of USD 25,338,000 and cash and cash equivalents of USD 4,471,000. Historical figures retain the originally filed amounts where later comparative figures differ.
Company overview
- Legal name
- INTEGRATED BIOPHARMA INC
- Former names in filing history
- INTEGRATED HEALTH TECHNOLOGIES INC (2002-09-12 to 2003-04-16); CHEM INTERNATIONAL INC (1996-12-09 to 2002-05-14)
- Classification
- Public company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Hillside, NJ, United States
- Incorporated in
- DE
- Fiscal year end
- June 30
- SEC CIK
- 0001016504
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2026USD | $43.9M | -$2.8M | $25.3M | $4.5M | $1.2M | |
| FY2025USD | $54.4M | $808,000 | $24.9M | $3.6M | $2.1M | |
| FY2024USD | $50.3M | $112,000 | $26.2M | $1.7M | $943,000 | |
| FY2023USD | $50.7M | -$34,000 | $25.4M | $1.3M | $1.2M |
FY2023. Total assets: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | FORM 8-K | ||
| 10-K | FORM 10-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K PNC FIRST AMENDMENT | ||
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research INTEGRATED BIOPHARMA INC in Altss
Track this company’s investors, transactions and relationships in Altss.